Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Insights Into China Biotech's New Approach: Spin-Off-NewCo Model

    China's pharmaceutical industry is witnessing a notable surge in "pipeline spin-off projects", a model commonly referred to as the "Spin-off-NewCo" or "SON"...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    China Compliance Update: Life Sciences — Summer 2026

    China's regulators intensified anti-corruption enforcement in the life sciences sector during the first half of 2026, introducing stricter oversight of medical data security, sales representatives, and public procurement processes. New administrative measures and judicial interpretations have lowered thresholds for criminal liability while expanding corporate accountability for employee misconduct.
    ChinaGovernment, Public Sector
Arnold & Porter
Arnold & Porter
  • Article

    New Developments Of China's Restrictions On Cross-Border Transfer Of Personal Information Under The PIPL

    On July 2, 2021, China's top ride-hailing platform Didi Chuxing was announced to be probed for cybersecurity review two days after its IPO in the US, closely followed by two similar probes against other Internet companies ...
    ChinaPrivacy
    Dentons
    Dentons
  • Article

    China's New Rules On Donations To Healthcare Entities - Implications For Multinational Companies

    In recent years, sponsorships and donations to Healthcare Entities have been the focus of multiple anti-corruption enforcement actions in China.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    China's New Rules On Donations To Healthcare Entities - Implications For Multinational Companies

    In recent years, sponsorships and donations to Healthcare Entities have been the focus of multiple anti-corruption enforcement actions in China.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Han Kun • Opinion | Brief Review Of The Measures For The Review Of Science And Technology Ethics (Trial) (Draft For Comments)

    On April 4, 2023, the Ministry of Science and Technology released the "Measures for Science and Technology Ethics Review (Trial) (Draft for Comments)" ("Draft for Comments")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    What Are The Contract Essentials For China-related Life Sciences Collaboration Agreements?

    China is becoming an increasing focus for transactions in the pharmaceuticals sector with its growing investment into research and development, government support and a steady...
    GlobalFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Part 2 - Toby's COVID-19 Survival Guide From Hong Kong

    I do not wish to define size of droplets and argue whether COVID-19 is airborne. Frankly I do not give a damn.
    ChinaCoronavirus (COVID-19)
    Toby Mak
    Toby Mak
  • Article

    Twelve Insurance Companies Get The Qualification Of Tax Preferential Health Insurance

    3月8日,保监会批准了第二批共9家险企税优型健康险的经营资格。至此,共有12家险企获得了该产品经营资格
    ChinaTax
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    A Legal Commentary On The Latest Implementing Regulations Of The PRC Drug Administration Law

    On January 16, 2026, the State Council of the People's Republic of China promulgated the revised Regulations for the Implementation of the Drug Administration Law (the "Implementing Regulations")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Fangda Partners
    Fangda Partners
  • Article

    Han Kun • Opinion | Quick Review Of The New Regulations: Interpret The Latest Questions And Answers Of The Ministry Of Science And Technology

    On September 8, 2023, the China Biotechnology Development Center directly under the Ministry of Science and Technology of the People's Republic of China...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Top 10 Traps To Avoid: Navigating China's HGR Applications

    Based on our experience, many projects that consider multiple factors and make separate arrangements for econo
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Redefining AI Research Ethical Boundaries? – FAQs On China's New Measures For Scientific Research And Innovations

    On October 8, 2023, the Ministry of Science and Technology, in collaboration with nine other national departments, unveiled the Measures for Review of Scientific and Technological Ethics...
    ChinaTechnology
    Zhong Lun Law Firm
    Zhong Lun Law Firm
  • Article

    Force Majeure In The Time Of Covid-19

    On February 11, 2020, the World Health Organization officially assigned the name "Covid-19" to the novel coronavirus that first appeared in Wuhan, China.
    ChinaCorporate/Commercial Law
    Lawson Lundell LLP
    Lawson Lundell LLP
  • Article

    特殊疾病医疗期延长规则:236号文的适用现状

    原劳动部1995年发布的《关于贯彻〈企业职工患病或非因工负伤医疗期规定〉的通知》(劳部发〔1995〕236号)第二条规定:“根据目前的实际情况,对某些患特殊疾病(如癌症、精神病、瘫痪等)的职工,在24个月内尚不能痊愈的,经企业和劳动主管部门批准,可以适当延长医疗期”。该条款的立法&
    ChinaEmployment and HR
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    汉坤 • 观点 | 中国药品年度报告制度简析

    2022年4月11日,国家药品监督管理局(" 国家药监局")发布了《药品年度报告管理规定》以及相应的报告模板(以下合称" 《年报规定》")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Understanding China's Pharmaceutical Patent Linkage System: Framework And Case Overview (Part 1)

    The fourth amendment to the Patent Law of the People's Republic of China (hereinafter, the "Patent Law") came into effect on June 1, 2021. In July of the same year, the Measures for the Implementation...
    ChinaIntellectual Property
    Chang Tsi & Partners
    Chang Tsi & Partners
  • Article

    Overview: 2022-2023 China Drug & Medical Device Annual Report

    China's National Medical Products Administration (NMPA) released the 2023 Drug Review Annual Report on its official website on February 4, 2024...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    "保险+互联网医疗"业态的合规要点

    Q1、如果保险公司本身不具备或仅具备部分"互联网+医疗"相关经营资质,其可以如何合规地向其客户提供互联网医疗及/或药品销售服务?根据本ࢰ
    ChinaInsurance
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    China Pilots Lifting Restrictions On Foreign Investment In Stem Cell, Gene Therapy, And Genetic Diagnosis Sectors In Four Free Trade Zones

    On September 8, 2024, the Ministry of Commerce, together with the National Health Commission and the National Medical Products Administration (hereinafter referred to as the "Three Departments"), publicly issued the Notice on Carrying Out Pilot Programs to Expand Opening-Up in the Healthcare Sector (hereinafter referred to as the "Notice")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Showing 161–180 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics